Cleared Special

K101677 - HOSPIRA INFUSION BLOOD SETS

K101677 is the FDA 510(k) clearance for HOSPIRA INFUSION BLOOD SETS by Hospira, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Special 510(k) pathway after a 57-day FDA review.

K101677 · Hospira, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
57d
Days
Class 2
Risk

K101677 is an FDA 510(k) clearance for the HOSPIRA INFUSION BLOOD SETS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Hospira, Inc. (Lake Forest, US). The FDA issued a Cleared decision on August 11, 2010 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Hospira, Inc. devices

Submission Details

510(k) Number K101677 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 2010
Decision Date August 11, 2010
Days to Decision 57 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 129d · This submission: 57d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 373
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K101677.
HIGH PRESSURE SETS-400 PSI
K100576 · Icu Medical, Inc. · Dec 2010
INFUSION SETS
K103344 · Hospira, Inc. · Dec 2010
ACCU-CHEK ULTRFLEX INFUSION SET
K101196 · Roche Diagnostics Corp. · Aug 2010
POLYFIN INFUSION SET, MODELS MMT-165, MMT-365, MMT-366, MMT-312S AND MMT-312L AND SOF-SET INFUSION SETS
K100432 · Medtronic Minimed · Jul 2010
CLAVE NEUTRON
K100434 · Icu Medical, Inc. · Jul 2010
DUAL LUER LOCK CAP, MODEL 2C6250
K101385 · Baxter Healthcare Corp · Jun 2010